QCR2_HUMAN - dbPTM
QCR2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID QCR2_HUMAN
UniProt AC P22695
Protein Name Cytochrome b-c1 complex subunit 2, mitochondrial
Gene Name UQCRC2
Organism Homo sapiens (Human).
Sequence Length 453
Subcellular Localization Mitochondrion inner membrane
Peripheral membrane protein
Matrix side.
Protein Description This is a component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex), which is part of the mitochondrial respiratory chain. The core protein 2 is required for the assembly of the complex..
Protein Sequence MKLLTRAGSFSRFYSLKVAPKVKATAAPAGAPPQPQDLEFTKLPNGLVIASLENYSPVSRIGLFIKAGSRYEDFSNLGTTHLLRLTSSLTTKGASSFKITRGIEAVGGKLSVTATRENMAYTVECLRGDVDILMEFLLNVTTAPEFRRWEVADLQPQLKIDKAVAFQNPQTHVIENLHAAAYRNALANPLYCPDYRIGKVTSEELHYFVQNHFTSARMALIGLGVSHPVLKQVAEQFLNMRGGLGLSGAKANYRGGEIREQNGDSLVHAAFVAESAVAGSAEANAFSVLQHVLGAGPHVKRGSNTTSHLHQAVAKATQQPFDVSAFNASYSDSGLFGIYTISQATAAGDVIKAAYNQVKTIAQGNLSNTDVQAAKNKLKAGYLMSVESSECFLEEVGSQALVAGSYMPPSTVLQQIDSVANADIINAAKKFVSGQKSMAASGNLGHTPFVDEL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9PhosphorylationKLLTRAGSFSRFYSL
CCCCCCCCCHHEEEE
21.0424719451
15PhosphorylationGSFSRFYSLKVAPKV
CCCHHEEEEECCCCC
20.9924719451
17UbiquitinationFSRFYSLKVAPKVKA
CHHEEEEECCCCCCC
30.3427667366
21UbiquitinationYSLKVAPKVKATAAP
EEEECCCCCCCCCCC
46.7822817900
23UbiquitinationLKVAPKVKATAAPAG
EECCCCCCCCCCCCC
46.2621906983
42UbiquitinationPQDLEFTKLPNGLVI
CCCCCEEECCCCEEE
68.2316196087
42AcetylationPQDLEFTKLPNGLVI
CCCCCEEECCCCEEE
68.2325038526
55PhosphorylationVIASLENYSPVSRIG
EEEEECCCCCCCEEE
12.65-
56PhosphorylationIASLENYSPVSRIGL
EEEECCCCCCCEEEE
30.33-
59PhosphorylationLENYSPVSRIGLFIK
ECCCCCCCEEEEEEE
22.89-
66UbiquitinationSRIGLFIKAGSRYED
CEEEEEEECCCCCHH
39.0823503661
66AcetylationSRIGLFIKAGSRYED
CEEEEEEECCCCCHH
39.0825825284
69PhosphorylationGLFIKAGSRYEDFSN
EEEEECCCCCHHHCC
36.2328152594
71PhosphorylationFIKAGSRYEDFSNLG
EEECCCCCHHHCCCC
22.8828152594
75PhosphorylationGSRYEDFSNLGTTHL
CCCCHHHCCCCHHHH
43.3928152594
80PhosphorylationDFSNLGTTHLLRLTS
HHCCCCHHHHHHHHH
14.5525332170
86PhosphorylationTTHLLRLTSSLTTKG
HHHHHHHHHCCCCCC
15.1620068231
87PhosphorylationTHLLRLTSSLTTKGA
HHHHHHHHCCCCCCC
28.1320068231
88PhosphorylationHLLRLTSSLTTKGAS
HHHHHHHCCCCCCCC
25.2120068231
90PhosphorylationLRLTSSLTTKGASSF
HHHHHCCCCCCCCCC
28.5420068231
91PhosphorylationRLTSSLTTKGASSFK
HHHHCCCCCCCCCCE
32.5420068231
92MalonylationLTSSLTTKGASSFKI
HHHCCCCCCCCCCEE
47.4426320211
92SuccinylationLTSSLTTKGASSFKI
HHHCCCCCCCCCCEE
47.4423954790
922-HydroxyisobutyrylationLTSSLTTKGASSFKI
HHHCCCCCCCCCCEE
47.44-
92UbiquitinationLTSSLTTKGASSFKI
HHHCCCCCCCCCCEE
47.4432142685
98SuccinylationTKGASSFKITRGIEA
CCCCCCCEEEECEEE
45.1523954790
982-HydroxyisobutyrylationTKGASSFKITRGIEA
CCCCCCCEEEECEEE
45.15-
98UbiquitinationTKGASSFKITRGIEA
CCCCCCCEEEECEEE
45.1527667366
98MethylationTKGASSFKITRGIEA
CCCCCCCEEEECEEE
45.1551163891
98AcetylationTKGASSFKITRGIEA
CCCCCCCEEEECEEE
45.1525953088
100PhosphorylationGASSFKITRGIEAVG
CCCCCEEEECEEEEC
24.35-
1092-HydroxyisobutyrylationGIEAVGGKLSVTATR
CEEEECCEEEEEEEE
31.49-
109UbiquitinationGIEAVGGKLSVTATR
CEEEECCEEEEEEEE
31.4923503661
111PhosphorylationEAVGGKLSVTATREN
EEECCEEEEEEEECH
22.40-
113PhosphorylationVGGKLSVTATRENMA
ECCEEEEEEEECHHE
20.95-
134SulfoxidationRGDVDILMEFLLNVT
HCCHHHHHHHHHCCC
3.3228183972
159SuccinylationADLQPQLKIDKAVAF
CCCCCCCCCCEEHHC
43.5423954790
159AcetylationADLQPQLKIDKAVAF
CCCCCCCCCCEEHHC
43.5423236377
159UbiquitinationADLQPQLKIDKAVAF
CCCCCCCCCCEEHHC
43.5422817900
1622-HydroxyisobutyrylationQPQLKIDKAVAFQNP
CCCCCCCEEHHCCCC
48.51-
162UbiquitinationQPQLKIDKAVAFQNP
CCCCCCCEEHHCCCC
48.5121906983
182PhosphorylationENLHAAAYRNALANP
HHHHHHHHHHHHCCC
10.32-
191PhosphorylationNALANPLYCPDYRIG
HHHCCCCCCCCCCCC
11.8228152594
192S-palmitoylationALANPLYCPDYRIGK
HHCCCCCCCCCCCCE
2.4526865113
195PhosphorylationNPLYCPDYRIGKVTS
CCCCCCCCCCCEECH
6.8328152594
199UbiquitinationCPDYRIGKVTSEELH
CCCCCCCEECHHHHH
39.7121906983
199AcetylationCPDYRIGKVTSEELH
CCCCCCCEECHHHHH
39.71-
201PhosphorylationDYRIGKVTSEELHYF
CCCCCEECHHHHHHH
33.6328857561
202PhosphorylationYRIGKVTSEELHYFV
CCCCEECHHHHHHHH
31.8728857561
207PhosphorylationVTSEELHYFVQNHFT
ECHHHHHHHHHHCCH
20.3328152594
214PhosphorylationYFVQNHFTSARMALI
HHHHHCCHHHHHHHH
17.5828152594
215PhosphorylationFVQNHFTSARMALIG
HHHHCCHHHHHHHHH
16.9728152594
226PhosphorylationALIGLGVSHPVLKQV
HHHHCCCCCHHHHHH
21.9224719451
231UbiquitinationGVSHPVLKQVAEQFL
CCCCHHHHHHHHHHH
42.8516196087
240SulfoxidationVAEQFLNMRGGLGLS
HHHHHHHCCCCCCCC
4.6028465586
241MethylationAEQFLNMRGGLGLSG
HHHHHHCCCCCCCCC
34.65115919545
247PhosphorylationMRGGLGLSGAKANYR
CCCCCCCCCCCCCCC
34.6026437602
2502-HydroxyisobutyrylationGLGLSGAKANYRGGE
CCCCCCCCCCCCCCC
40.46-
250AcetylationGLGLSGAKANYRGGE
CCCCCCCCCCCCCCC
40.4627452117
250SuccinylationGLGLSGAKANYRGGE
CCCCCCCCCCCCCCC
40.4623954790
250UbiquitinationGLGLSGAKANYRGGE
CCCCCCCCCCCCCCC
40.4627667366
254MethylationSGAKANYRGGEIREQ
CCCCCCCCCCCCCCC
46.58115919549
301MethylationGAGPHVKRGSNTTSH
CCCCCCCCCCCCHHH
53.32115919553
303PhosphorylationGPHVKRGSNTTSHLH
CCCCCCCCCCHHHHH
34.7325850435
305PhosphorylationHVKRGSNTTSHLHQA
CCCCCCCCHHHHHHH
31.2225850435
306PhosphorylationVKRGSNTTSHLHQAV
CCCCCCCHHHHHHHH
20.5726657352
307PhosphorylationKRGSNTTSHLHQAVA
CCCCCCHHHHHHHHH
23.2425850435
317PhosphorylationHQAVAKATQQPFDVS
HHHHHHHHCCCCCCE
27.3428985074
329PhosphorylationDVSAFNASYSDSGLF
CCEEEECCCCCCCEE
26.6928985074
342PhosphorylationLFGIYTISQATAAGD
EEEEEEEECCHHHHH
13.1328985074
359AcetylationKAAYNQVKTIAQGNL
HHHHHHHHHHHCCCC
25.1723236377
359SuccinylationKAAYNQVKTIAQGNL
HHHHHHHHHHHCCCC
25.1727452117
359UbiquitinationKAAYNQVKTIAQGNL
HHHHHHHHHHHCCCC
25.1721963094
359MalonylationKAAYNQVKTIAQGNL
HHHHHHHHHHHCCCC
25.1732601280
360PhosphorylationAAYNQVKTIAQGNLS
HHHHHHHHHHCCCCC
23.7627251275
367O-linked_GlycosylationTIAQGNLSNTDVQAA
HHHCCCCCHHHHHHH
41.5029351928
367PhosphorylationTIAQGNLSNTDVQAA
HHHCCCCCHHHHHHH
41.5028857561
369PhosphorylationAQGNLSNTDVQAAKN
HCCCCCHHHHHHHHH
33.8828857561
369O-linked_GlycosylationAQGNLSNTDVQAAKN
HCCCCCHHHHHHHHH
33.8829351928
3752-HydroxyisobutyrylationNTDVQAAKNKLKAGY
HHHHHHHHHHCCCCE
58.60-
375UbiquitinationNTDVQAAKNKLKAGY
HHHHHHHHHHCCCCE
58.6027667366
377UbiquitinationDVQAAKNKLKAGYLM
HHHHHHHHCCCCEEE
51.1322817900
379UbiquitinationQAAKNKLKAGYLMSV
HHHHHHCCCCEEEEE
41.1822817900
429AcetylationADIINAAKKFVSGQK
HHHHHHHHHHHCCCC
44.3130593273
430UbiquitinationDIINAAKKFVSGQKS
HHHHHHHHHHCCCCC
46.3927667366
436UbiquitinationKKFVSGQKSMAASGN
HHHHCCCCCHHCCCC
45.8023503661
447PhosphorylationASGNLGHTPFVDEL-
CCCCCCCCCCCCCC-
19.34-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of QCR2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of QCR2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of QCR2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RTN4_HUMANRTN4physical
12067236
SRSF5_HUMANSRSF5physical
22939629
ZN326_HUMANZNF326physical
22939629
AFG32_HUMANAFG3L2physical
26344197
ATD3A_HUMANATAD3Aphysical
26344197
ATPA_HUMANATP5A1physical
26344197
ATPG_HUMANATP5C1physical
26344197
TCPQ_HUMANCCT8physical
26344197
CLH1_HUMANCLTCphysical
26344197
COPB_HUMANCOPB1physical
26344197
COX41_HUMANCOX4I1physical
26344197
DX39B_HUMANDDX39Bphysical
26344197
ROA3_HUMANHNRNPA3physical
26344197
HNRPK_HUMANHNRNPKphysical
26344197
ENPL_HUMANHSP90B1physical
26344197
IDE_HUMANIDEphysical
26344197
IMA3_HUMANKPNA4physical
26344197
NDUAC_HUMANNDUFA12physical
26344197
NDUA9_HUMANNDUFA9physical
26344197
NDUB8_HUMANNDUFB8physical
26344197
NDUS1_HUMANNDUFS1physical
26344197
NDUS3_HUMANNDUFS3physical
26344197
NDUS4_HUMANNDUFS4physical
26344197
PDIA1_HUMANP4HBphysical
26344197
GLU2B_HUMANPRKCSHphysical
26344197
RAB1B_HUMANRAB1Bphysical
26344197
RAB6B_HUMANRAB6Bphysical
26344197
RPN1_HUMANRPN1physical
26344197
ACOD_HUMANSCDphysical
26344197
SCD5_HUMANSCD5physical
26344197
S61A1_HUMANSEC61A1physical
26344197
SSRG_HUMANSSR3physical
26344197
SSRD_HUMANSSR4physical
26344197
TMCO1_HUMANTMCO1physical
26344197
TOM22_HUMANTOMM22physical
26344197
TPM2_HUMANTPM2physical
26344197
TPM3_HUMANTPM3physical
26344197
EFTU_HUMANTUFMphysical
26344197
VDAC1_HUMANVDAC1physical
26344197
VDAC2_HUMANVDAC2physical
26344197
STOM_HUMANSTOMphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
615160Mitochondrial complex III deficiency, nuclear 5 (MC3DN5)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of QCR2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-86, AND MASSSPECTROMETRY.

TOP